HIV-1 viral load in SCD trait at Howard University
Characteristic . | AA . | AS . | P . | ||
---|---|---|---|---|---|
. | N . | Results . | N . | Results . | |
Age, y | 110 | 34 (19-47) | 9 | 54 (41-55) | .009 |
Female sex | 110 | 77 (70%) | 9 | 5 (56%) | .37 |
HIV related complication | 110 | 29 (26%) | 9 | 0 | .08 |
Duration of disease, y | 108 | 12 (5-17) | 9 | 13 (9-16) | .4 |
HIV medication | 110 | 103 (94%) | 9 | 9 (100%) | .4 |
Hb | 94 | 12.6 (11.6-13.5) | 9 | 12.9 (10.9-13.4) | >.9 |
Platelet | 94 | 255 (206-311) | 9 | 247 (198-270) | .8 |
WBC | 94 | 5.3 (4.0-7.0) | 9 | 4.7 (4.3-5.2) | .5 |
CD4 counts | 91 | 525 (272-770) | 9 | 498 (329-595) | .6 |
First CD8 counts | 91 | 888 (682-1399) | 9 | 599 (482-886) | .08 |
Viral load* | 87 | 220 (20-8350) | 7 | 20 (20-20) | <.0001† |
Mean viral load | 103 | 647 (20-12 530) | 9 | 20 (20-20) | .031‡ |
Characteristic . | AA . | AS . | P . | ||
---|---|---|---|---|---|
. | N . | Results . | N . | Results . | |
Age, y | 110 | 34 (19-47) | 9 | 54 (41-55) | .009 |
Female sex | 110 | 77 (70%) | 9 | 5 (56%) | .37 |
HIV related complication | 110 | 29 (26%) | 9 | 0 | .08 |
Duration of disease, y | 108 | 12 (5-17) | 9 | 13 (9-16) | .4 |
HIV medication | 110 | 103 (94%) | 9 | 9 (100%) | .4 |
Hb | 94 | 12.6 (11.6-13.5) | 9 | 12.9 (10.9-13.4) | >.9 |
Platelet | 94 | 255 (206-311) | 9 | 247 (198-270) | .8 |
WBC | 94 | 5.3 (4.0-7.0) | 9 | 4.7 (4.3-5.2) | .5 |
CD4 counts | 91 | 525 (272-770) | 9 | 498 (329-595) | .6 |
First CD8 counts | 91 | 888 (682-1399) | 9 | 599 (482-886) | .08 |
Viral load* | 87 | 220 (20-8350) | 7 | 20 (20-20) | <.0001† |
Mean viral load | 103 | 647 (20-12 530) | 9 | 20 (20-20) | .031‡ |